INOVIO PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
INOVIO PHARMACEUTICALS, INC. (INO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 40.74 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-03-12
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 40.74K shares, a 5.80% increase from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 38.50K shares, a 311.49% increase from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 9.36K shares, a 45.36% increase from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 6.44K shares, a 1004.12% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|
| 2025-12-31 | 40.74K shares 10-K · filed 2026-03-12 | |
| 2024-12-31 | 38.50K shares 10-K · filed 2026-03-12 | |
| 2023-12-31 | 9.36K shares 10-K · filed 2025-03-18 | |
| 2022-12-31 | 6.44K shares 10-K · filed 2024-03-06 | 77.25K shares 10-K · filed 2023-03-01 |
| 2021-12-31 | 583.00 shares 10-K · filed 2024-03-06 | 7.00K shares 10-K · filed 2022-03-01 |
| 2020-12-31 | 78.75K shares 10-K · filed 2023-03-01 | |
| 2019-12-31 | 324.50K shares 10-K · filed 2022-03-01 | |
| 2018-12-31 | 119.09K shares 10-K · filed 2021-03-01 | |
| 2017-12-31 | 200.50K shares 10-K · filed 2020-03-12 | |
| 2016-12-31 | 69.57K shares 10-K · filed 2019-03-12 | |
| 2015-12-31 | 83.70K shares 10-K · filed 2018-03-14 | |
| 2014-12-31 | 70.52K shares 10-K · filed 2017-03-15 | |
| 2013-12-31 | 124.00K shares 10-K · filed 2016-03-14 | 496.01K shares 10-K · filed 2014-03-17 |
| 2012-12-31 | 51.88K shares 10-K · filed 2015-03-16 | 207.50K shares 10-K · filed 2013-03-18 |
| 2011-12-31 | 100.00K shares 10-K · filed 2014-03-17 | |
| 2010-12-31 | 4.25K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |